A citation-based method for searching scientific literature

Daniel T MacLeod, Jeyaraj Antony, Aaron J Martin, Rachel J Moser, Armin Hekele, Keith J Wetzel, Audrey E Brown, Melissa A Triggiano, Jo Ann Hux, Christina D Pham, Victor V Bartsevich, Caitlin A Turner, Janel Lape, Samantha Kirkland, Clayton W Beard, Jeff Smith, Matthew L Hirsch, Michael G Nicholson, Derek Jantz, Bruce McCreedy. Mol Ther 2017
Times Cited: 135



Xiaojuan Liu, Yongping Zhang, Chen Cheng, Albert W Cheng, Xingying Zhang, Na Li, Changqing Xia, Xiaofei Wei, Xiang Liu, Haoyi Wang. Cell Res 2017
Times Cited: 194




List of shared articles



Times cited

Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies.
Binod Dhakal, Saurabh Chhabra, Bipin N Savani, Mehdi Hamadani. Br J Haematol 2022
2

Strategies to overcome the side effects of chimeric antigen receptor T cell therapy.
Mohadeseh Mirzaee Godarzee, Bashdar Mahmud Hussen, Ehsan Razmara, Benyamin Hakak-Zargar, Fatemeh Mohajerani, Hamed Dabiri, Mohammed Fatih Rasul, Mohammad Hossein Ghazimoradi, Sadegh Babashah, Majid Sadeghizadeh. Ann N Y Acad Sci 2022
0

New Indications and platforms for CAR-T therapy in lymphomas beyond DLBCL.
Madiha Iqbal, Bipin N Savani, Mehdi Hamadani. EJHaem 2022
2

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing.
Alexander Dimitri, Friederike Herbst, Joseph A Fraietta. Mol Cancer 2022
12

CRISPR Takes the Front Seat in CART-Cell Development.
Claudia Manriquez-Roman, Elizabeth L Siegler, Saad S Kenderian. BioDrugs 2021
6

Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity.
Avery J Lam, David T S Lin, Jana K Gillies, Prakruti Uday, Anne M Pesenacker, Michael S Kobor, Megan K Levings. Cell Rep 2021
13

Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells.
Melita Irving, Evripidis Lanitis, Denis Migliorini, Zoltán Ivics, Sonia Guedan. Hum Gene Ther 2021
10

Adeno-Associated Viral Vectors for Homology-Directed Generation of CAR-T Cells.
Pablo D Moço, Noga Aharony, Amine Kamen. Biotechnol J 2020
5

Engineering strategies to overcome the current roadblocks in CAR T cell therapy.
Sarwish Rafiq, Christopher S Hackett, Renier J Brentjens. Nat Rev Clin Oncol 2020
426

Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy.
Xingying Zhang, Chen Cheng, Wen Sun, Haoyi Wang. Methods Mol Biol 2020
6

CRISPR/Cas systems to overcome challenges in developing the next generation of T cells for cancer therapy.
Dennis Huang, Matthew Miller, Bhaargavi Ashok, Samagra Jain, Nicholas A Peppas. Adv Drug Deliv Rev 2020
9

Engineering CAR-T Cells for Next-Generation Cancer Therapy.
Mihe Hong, Justin D Clubb, Yvonne Y Chen. Cancer Cell 2020
180

Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors.
Vania Lo Presti, Frank Buitenwerf, Niek P van Til, Stefan Nierkens. Vaccines (Basel) 2020
8

Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome Editing.
Jie Liu, Guangyu Zhou, Li Zhang, Qi Zhao. Front Immunol 2019
45